Beranda › Penyakit Hati › Michigan
Uji klinis Penyakit Hati di Michigan
8 studi untuk Penyakit Hati mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chesterfield
- 89bio Clinical Study Site, Wyoming
- 89bio Clinical Study Site, Ypsilanti
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Ann Arbor
- 89bio Clinical Study Site, Clinton Township
- 89bio Clinical Study Site, Detroit
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06419374A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Ann Arbor
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT06600321Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
- Henry Ford Transplant Institute, Detroit
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT03193151DILIN - Prospective Study
- University of Michigan, Ann Arbor
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 8 Apr 2026 · NCT00345930Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
- Henry Ford Health, Detroit
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT06269510A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Henry Ford Cancer Institute, Detroit
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
- University of Michigan, Ann Arbor
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Okt 2025 · NCT05733832Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.